Cargando…

Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients With T2DM by (1)H-MRS

Objective: To explore the correlation between diabetic cognitive impairment (DCI) and diabetic retinopathy (DR) through examining the cognitive function and the metabolism of the cerebrum in Type 2 diabetes mellitus (T2DM) by (1)H-MRS. Methods: Fifty-three patients with T2DM were enrolled for this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xuefang, Gong, Wei, Wen, Zhi, Hu, Lanhua, Peng, Zhoufeng, Zha, Yunfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861416/
https://www.ncbi.nlm.nih.gov/pubmed/31781013
http://dx.doi.org/10.3389/fneur.2019.01068
_version_ 1783471351877599232
author Lu, Xuefang
Gong, Wei
Wen, Zhi
Hu, Lanhua
Peng, Zhoufeng
Zha, Yunfei
author_facet Lu, Xuefang
Gong, Wei
Wen, Zhi
Hu, Lanhua
Peng, Zhoufeng
Zha, Yunfei
author_sort Lu, Xuefang
collection PubMed
description Objective: To explore the correlation between diabetic cognitive impairment (DCI) and diabetic retinopathy (DR) through examining the cognitive function and the metabolism of the cerebrum in Type 2 diabetes mellitus (T2DM) by (1)H-MRS. Methods: Fifty-three patients with T2DM were enrolled for this study. According to the fundus examination, the patients were divided into the DR group (n = 26) and the T2DM without DR group (T2DM group, n = 27). Thirty healthy adults were selected as a control group (HC group, n = 30). Cognitive function was measured by Montreal Cognitive Assessment (MoCA). The peak areas of N-acetylaspartate (NAA), Cho-line (Cho), Creatine (Cr), and Myo-inositol (mI) as well as their ratios were detected by proton magnetic resonance spectroscopy ((1)H-MRS). The difference analysis between the three groups was performed by one-way ANOVA. When p < 0.05, LSD-t was applied. A partial correlation analysis (with age as a covariate) was used to analyze the correlation between metabolites in the DR group and MoCA scores. Among all T2DM patients, Chi-square test age, gender, education level, BMI, SBP, DBP, FPG, HbA1c, TC, TG, HDL-C, LDL-C, DR, and DCI correlation were measured. Differences were statistically significant while P < 0.05. Results: 1. The scores of MoCA in the DR group or in the T2DM group were significantly less than those in the HC group (F = 3.54, P < 0.05), and the scores of MoCA in the DR group were significantly less than those in the other groups (F = 3.61, P < 0.05). 2. There were significant differences for NAA in the bilateral hippocampus in DR patients, T2DM patients, and healthy controls (P < 0.05). 3. The NAA/Cr was significantly positively correlated with the score of MoCA in DR patients' left hippocampus (r = 0.781, P < 0.01). 4. Chi-square analysis found that there was a correlation between DR and DCI (x(2) = 4.6, df = 1, p = 0.032, plt: 0.05). There was no correlation between other influencing factors and DCI (P > 0.05). Conclusion: DCI is closely correlated with the DR in patients with T2DM. Hippocampal brain metabolism may have some changes in two sides of NAA in patients with DR, (1)H-MRS may provide effective imaging strategies and methods for the early diagnosis of brain damage and quantitative assessment cognitive function in T2DM.
format Online
Article
Text
id pubmed-6861416
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68614162019-11-28 Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients With T2DM by (1)H-MRS Lu, Xuefang Gong, Wei Wen, Zhi Hu, Lanhua Peng, Zhoufeng Zha, Yunfei Front Neurol Neurology Objective: To explore the correlation between diabetic cognitive impairment (DCI) and diabetic retinopathy (DR) through examining the cognitive function and the metabolism of the cerebrum in Type 2 diabetes mellitus (T2DM) by (1)H-MRS. Methods: Fifty-three patients with T2DM were enrolled for this study. According to the fundus examination, the patients were divided into the DR group (n = 26) and the T2DM without DR group (T2DM group, n = 27). Thirty healthy adults were selected as a control group (HC group, n = 30). Cognitive function was measured by Montreal Cognitive Assessment (MoCA). The peak areas of N-acetylaspartate (NAA), Cho-line (Cho), Creatine (Cr), and Myo-inositol (mI) as well as their ratios were detected by proton magnetic resonance spectroscopy ((1)H-MRS). The difference analysis between the three groups was performed by one-way ANOVA. When p < 0.05, LSD-t was applied. A partial correlation analysis (with age as a covariate) was used to analyze the correlation between metabolites in the DR group and MoCA scores. Among all T2DM patients, Chi-square test age, gender, education level, BMI, SBP, DBP, FPG, HbA1c, TC, TG, HDL-C, LDL-C, DR, and DCI correlation were measured. Differences were statistically significant while P < 0.05. Results: 1. The scores of MoCA in the DR group or in the T2DM group were significantly less than those in the HC group (F = 3.54, P < 0.05), and the scores of MoCA in the DR group were significantly less than those in the other groups (F = 3.61, P < 0.05). 2. There were significant differences for NAA in the bilateral hippocampus in DR patients, T2DM patients, and healthy controls (P < 0.05). 3. The NAA/Cr was significantly positively correlated with the score of MoCA in DR patients' left hippocampus (r = 0.781, P < 0.01). 4. Chi-square analysis found that there was a correlation between DR and DCI (x(2) = 4.6, df = 1, p = 0.032, plt: 0.05). There was no correlation between other influencing factors and DCI (P > 0.05). Conclusion: DCI is closely correlated with the DR in patients with T2DM. Hippocampal brain metabolism may have some changes in two sides of NAA in patients with DR, (1)H-MRS may provide effective imaging strategies and methods for the early diagnosis of brain damage and quantitative assessment cognitive function in T2DM. Frontiers Media S.A. 2019-11-12 /pmc/articles/PMC6861416/ /pubmed/31781013 http://dx.doi.org/10.3389/fneur.2019.01068 Text en Copyright © 2019 Lu, Gong, Wen, Hu, Peng and Zha. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Lu, Xuefang
Gong, Wei
Wen, Zhi
Hu, Lanhua
Peng, Zhoufeng
Zha, Yunfei
Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients With T2DM by (1)H-MRS
title Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients With T2DM by (1)H-MRS
title_full Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients With T2DM by (1)H-MRS
title_fullStr Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients With T2DM by (1)H-MRS
title_full_unstemmed Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients With T2DM by (1)H-MRS
title_short Correlation Between Diabetic Cognitive Impairment and Diabetic Retinopathy in Patients With T2DM by (1)H-MRS
title_sort correlation between diabetic cognitive impairment and diabetic retinopathy in patients with t2dm by (1)h-mrs
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861416/
https://www.ncbi.nlm.nih.gov/pubmed/31781013
http://dx.doi.org/10.3389/fneur.2019.01068
work_keys_str_mv AT luxuefang correlationbetweendiabeticcognitiveimpairmentanddiabeticretinopathyinpatientswitht2dmby1hmrs
AT gongwei correlationbetweendiabeticcognitiveimpairmentanddiabeticretinopathyinpatientswitht2dmby1hmrs
AT wenzhi correlationbetweendiabeticcognitiveimpairmentanddiabeticretinopathyinpatientswitht2dmby1hmrs
AT hulanhua correlationbetweendiabeticcognitiveimpairmentanddiabeticretinopathyinpatientswitht2dmby1hmrs
AT pengzhoufeng correlationbetweendiabeticcognitiveimpairmentanddiabeticretinopathyinpatientswitht2dmby1hmrs
AT zhayunfei correlationbetweendiabeticcognitiveimpairmentanddiabeticretinopathyinpatientswitht2dmby1hmrs